Atopic dermatitis
Conditions
Interventions
Control group:treatment with antihistamine therapy and topical steroid
Experimental group:treatment with antihistamine therapy and topical steroid combined use of STS and cytokine X
Sponsors
Dermatology Hospital of Southern Medical University
Eligibility
Sex/Gender
All
Age
12 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Age 12-65 years old; 2. Meet the Hanfin and Rajka diagnostic criteria of atopic dermatitis; 3. Total SCORAD 25 scores or higher; 4. The investigator's global assessment 3 scores or higher; 5. The chronic atopic dermatitis present for 3 years or longer; 6. The atopic dermatitis not adequately controlled by topical treatments; 7. Vital signs stable; 8. The subject has signed the written informed consent of the study and compliant this clinical research plan.
Exclusion criteria
Exclusion criteria: 1. Pregnant woman or breast-feeding woman; 2. Abnormal immune function, abnormal kidney and liver function, serious cardiovascular disease, malignant tumor, acute and chronic infection, and any other diseases which may interference test results; 3. Bad control of blood glucose, blood pressure and other disease; 4. Antibiotics, hormones and immunosuppressants were used in the past 1 month; 5. People with mental illness or who cannot cooperate in treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the SCORAD Index;The investigator's global assessment;EASI 50;EASI 75; | — |
Secondary
| Measure | Time frame |
|---|---|
| numerical rating scale for pruritus; | — |
Countries
China
Contacts
Public ContactLiang Yunsheng
Dermatology Hospital of Southern Medical University
Outcome results
None listed